Related references
Note: Only part of the references are listed.Subtherapeutic Initial β-Lactam Concentrations in Select Critically Ill Patients Association Between Augmented Renal Clearance and Low Trough Drug Concentrations
Andrew A. Udy et al.
CHEST (2012)
What's behind the failure of emerging antibiotics in the critically ill? Understanding the impact of altered pharmacokinetics and augmented renal clearance
Andrew A. Udy et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review
Fekade Bruck Sime et al.
ANNALS OF INTENSIVE CARE (2012)
Hypoalbuminemia in Critically III Patients With Cancer: Incidence and Mortality
Silvio A. Namendys-Silva et al.
AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE (2011)
Antibiotic Dosing in Multiple Organ Dysfunction Syndrome
Marta Ulldemolins et al.
CHEST (2011)
The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients
Marta Ulldemolins et al.
CLINICAL PHARMACOKINETICS (2011)
Using PK/PD to Optimize Antibiotic Dosing for Critically Ill Patients
Jason A. Roberts
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Plasma protein binding may reduce antimicrobial activity by preventing intra-bacterial uptake of antibiotics, for example clindamycin
A. Burian et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
The pharmacokinetics of cefazolin in patients undergoing elective & semi-elective abdominal aortic aneurysm open repair surgery
Alexandra Douglas et al.
BMC ANESTHESIOLOGY (2011)
Antibiotic dosing in the 'at risk' critically ill patient: Linking pathophysiology with pharmacokinetics/pharmacodynamics in sepsis and trauma patients
Jason A. Roberts et al.
BMC ANESTHESIOLOGY (2011)
Augmented Renal Clearance Implications for Antibacterial Dosing in the Critically Ill
Andrew A. Udy et al.
CLINICAL PHARMACOKINETICS (2010)
Augmented renal clearance in the Intensive Care Unit: an illustrative case series
Andrew A. Udy et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Therapeutic drug monitoring of β-lactams in critically ill patients: proof of concept
Jason A. Roberts et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics
Marta Ulldemolins et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Analysis of 12 beta-lactam antibiotics in human plasma by HPLC with ultraviolet detection
Brett C. McWhinney et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2010)
The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery
Dennis A. Smith et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Insufficient beta-lactam concentrations in the early phase of severe sepsis and septic shock
Fabio Silvio Taccone et al.
CRITICAL CARE (2010)
Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis
A. J. Brink et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Pharmacokinetic evaluation of single-dose intravenous daptomycin in patients with thermal burn injury
John F. Mohr et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Clinical relevance of pharmacokinetics and pharmacodynamics in cardiac critical care patients
Federico Pea et al.
CLINICAL PHARMACOKINETICS (2008)
Impact of pH on plasma protein binding in equilibrium dialysis
Christopher J. Kochansky et al.
MOLECULAR PHARMACEUTICS (2008)
Population pharmacokinetics at two dose levels and pharmacodynamic profiling of flucloxacillin
Cornelia B. Landersdorfer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SATE) study
Simon Finfer et al.
BRITISH MEDICAL JOURNAL (2006)
The antimicrobial therapy puzzle: Could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients?
Federico Pea et al.
CLINICAL INFECTIOUS DISEASES (2006)
Antibacterial dosing in intensive care - Pharmacokinetics, degree of disease and pharmacodynamics of sepsis
Jason A. Roberts et al.
CLINICAL PHARMACOKINETICS (2006)
The pH dependency of the binding of drugs to plasma proteins in man
PH Hinderling et al.
THERAPEUTIC DRUG MONITORING (2005)
Antimicrobial therapy in critically ill patients - A review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability
F Pea et al.
CLINICAL PHARMACOKINETICS (2005)
Teicoplanin in patients with acute leukaemia and febrile neutropenia - A special population benefiting from higher dosages
F Pea et al.
CLINICAL PHARMACOKINETICS (2004)
Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers
MWR Pletz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Pharmacokinetics and pharmacodynamics of sequential intravenous and subcutaneous teicoplanin in critically ill patients without vasopressors
A Barbot et al.
INTENSIVE CARE MEDICINE (2003)
Hypoalbuminemia as a risk factor for over-anticoagulation
E Tincani et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Therapeutic drug monitoring-guided high teicoplanin dosage regimen required to treat a hypoalbuminemic renal transplant patient undergoing continuous venovenous hemofiltration
F Pea et al.
THERAPEUTIC DRUG MONITORING (2001)
The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients
GM Joynt et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Share Paper
